메뉴 건너뛰기




Volumn 54, Issue 11, 2013, Pages 2441-2447

Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma

Author keywords

CHOP; Diffuse large B cell lymphoma; Elderly; Reduced; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

EID: 84885648096     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.780654     Document Type: Article
Times cited : (23)

References (20)
  • 1
    • 30144443996 scopus 로고    scopus 로고
    • Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001
    • Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107:265-276.
    • (2006) Blood , vol.107 , pp. 265-276
    • Morton, L.M.1    Wang, S.S.2    Devesa, S.S.3
  • 2
    • 0037165261 scopus 로고    scopus 로고
    • CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
    • Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242.
    • (2002) N Engl J Med , vol.346 , pp. 235-242
    • Coiffier, B.1    Lepage, E.2    Briere, J.3
  • 3
    • 23044503407 scopus 로고    scopus 로고
    • Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-Cell lymphoma: A study by the groupe d?Etude des Lymphomes de l?Adulte
    • Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-Cell lymphoma: A study by the groupe d?Etude des Lymphomes de l?Adulte. J Clin Oncol 2005;23:4117-4126.
    • (2005) J Clin Oncol , vol.23 , pp. 4117-4126
    • Feugier, P.1    Van Hoof, A.2    Sebban, C.3
  • 4
    • 77957200763 scopus 로고    scopus 로고
    • Long-term outcome of patients in the LNH-98.5 trial the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the groupe d?Etudes des Lymphomes de l?Adulte
    • Cuiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: A study by the groupe d?Etudes des Lymphomes de l?Adulte. Blood 2010;116:2040-2045.
    • (2010) Blood , vol.116 , pp. 2040-2045
    • Cuiffier, B.1    Thieblemont, C.2    Van Den Neste, E.3
  • 5
    • 38549147027 scopus 로고    scopus 로고
    • Sixversus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD2O + B-Cell lymphomas: A randomised controlled trial (RICOVER-60)
    • Pfreundschuh M, Schubert J, Ziepert M, et al. Sixversus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD2O + B-Cell lymphomas: A randomised controlled trial (RICOVER-60). Lancet Oncol 2008;9:105-116.
    • (2008) Lancet Oncol , vol.9 , pp. 105-116
    • Pfreundschuh, M.1    Schubert, J.2    Ziepert, M.3
  • 6
    • 0021282245 scopus 로고
    • Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly:Increased complications with advancing age
    • Armitage JO, Potter JR Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly:Increased complications with advancing age. JAm Geriatr Soc 1984;32:269-273.
    • (1984) JAm Geriatr Soc , vol.32 , pp. 269-273
    • Armitage, J.O.1    Potter, J.R.2
  • 7
    • 0022602852 scopus 로고
    • Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma:The Southwest Oncology Group experience
    • Dixon DO, Neilan B, Jones SE, et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma:The Southwest Oncology Group experience. J Clin Oncol 1986;4:295-305.
    • (1986) J Clin Oncol , vol.4 , pp. 295-305
    • Dixon, D.O.1    Neilan, B.2    Jones, S.E.3
  • 8
    • 0025063109 scopus 로고
    • Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables
    • Epelbaum R, Faraggi D, Ben-Arie Y, et al. Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variables. Cancer 1990;66:1124-1129.
    • (1990) Cancer , vol.66 , pp. 1124-1129
    • Epelbaum, R.1    Faraggi, D.2    Ben-Arie, Y.3
  • 9
    • 0025363033 scopus 로고
    • Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis
    • Kwak LW, Halpern J, Olshen BA, et al. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis. J Clin Oncol 1990;8:963-977.
    • (1990) J Clin Oncol , vol.8 , pp. 963-977
    • Kwak, L.W.1    Halpern, J.2    Olshen, B.A.3
  • 10
    • 0027495838 scopus 로고
    • Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: Application to LNH-87 protocol. The GELA. (Groupe Detude des Lymphomes de Iadulte)
    • Lepage E, Gisselbrecht C, Haioun C, et al. Prognostic significance of received relative dose intensity in non-Hodgkin?s lymphoma patients: Application to LNH-87 protocol. The GELA. (Groupe d?Etude des Lymphomes de l?Adulte). Ann Oncol 1993;4:651-656.
    • (1993) Ann Oncol , vol.4 , pp. 651-656
    • Lepage, E.1    Gisselbrecht, C.2    Haioun, C.3
  • 11
    • 0029095966 scopus 로고
    • Randomized phase 11 comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma
    • Meyer RM, Browman GP, Samosh ML, et al. Randomized phase 11 comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin?s lymphoma. J Clin Oncol 1995;13:2386-2393.
    • (1995) J Clin Oncol , vol.13 , pp. 2386-2393
    • Meyer, R.M.1    Browman, G.P.2    Samosh, M.L.3
  • 12
    • 0029162440 scopus 로고
    • Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy
    • Sonneveld P, de Ridder M, Van Der Lelie H, et al. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin?s lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol 1995;13:2530-2539.
    • (1995) J Clin Oncol , vol.13 , pp. 2530-2539
    • Sonneveld, P.1    De Ridder, M.2    Van Der Lelie, H.3
  • 13
    • 7344231043 scopus 로고    scopus 로고
    • Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma
    • Central Lymphoma Group
    • Bailey NP, Stuart NS, Bessell EM, et al. Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin?s lymphoma. Central Lymphoma Group. Ann Oncol 1998;9:633-638.
    • (1998) Ann Oncol , vol.9 , pp. 633-638
    • Bailey, N.P.1    Stuart, N.S.2    Bessell, E.M.3
  • 14
    • 0004815869 scopus 로고    scopus 로고
    • CHOP is the standard regimen in patients > or 70 years of age with intermediate-grade and high-grade non-Hodgkins lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
    • TirelliU, Errante D, Van Glabbeke M, et al. CHOP is the standard regimen in patients or 70 years of age with intermediate-grade and high-grade non-Hodgkin?s lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998; 16:27-34.
    • (1998) J Clin Oncol , vol.16 , pp. 27-34
    • Tirelli, U.1    Errante, D.2    Van Glabbeke, M.3
  • 15
    • 41249092380 scopus 로고    scopus 로고
    • Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-Cell lymphoma patients treated with CHOP
    • Bosly A, Bron D, Van Hoof A, et al. Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-Cell lymphoma patients treated with CHOP. Ann Hematol 2008;87:277-283.
    • (2008) Ann Hematol , vol.87 , pp. 277-283
    • Bosly, A.1    Bron, D.2    Van Hoof, A.3
  • 16
    • 77955660165 scopus 로고    scopus 로고
    • Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-Cell lymphoma
    • Hirakawa T, Yamaguchi H, Yokose N, et al. Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-Cell lymphoma. Ann Hematol 2010;89:897-904.
    • (2010) Ann Hematol , vol.89 , pp. 897-904
    • Hirakawa, T.1    Yamaguchi, H.2    Yokose, N.3
  • 17
    • 79955473473 scopus 로고    scopus 로고
    • Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-Cell lymphoma: A multicentre, single-arm, phase 2 trial
    • Peyrade F, Jardin F, Thieblemont C, et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-Cell lymphoma: A multicentre, single-arm, phase 2 trial. Lancet Oncol 2011;12:460-468.
    • (2011) Lancet Oncol , vol.12 , pp. 460-468
    • Peyrade, F.1    Jardin, F.2    Thieblemont, C.3
  • 18
    • 0023092594 scopus 로고
    • A newmethod of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales XL, et al. A newmethod of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, X.L.3
  • 19
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group
    • Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin?s lymphomas. NCI Sponsored International Working Group. J din Oncol 1999; 17: 1244.
    • (1999) J Din Oncol , vol.17 , pp. 1244
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 20
    • 77957371624 scopus 로고    scopus 로고
    • Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-Cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793). Consideration of age greater than 70 years in an elderly prognostic index (E-1PI)
    • Advani RH, Chen H, Habermann TM, et al. Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-Cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): Consideration of age greater than 70 years in an elderly prognostic index (E-1PI). Br Haematol 2010;151:143-151.
    • (2010) Br Haematol , vol.151 , pp. 143-151
    • Advani, R.H.1    Chen, H.2    Habermann, T.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.